Zemuron and Etomidate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zemuron (rocuronium bromide) and Etomidate (etomidate). Common drug interactions include aspartate aminotransferase increased among females and injury among males.

The phase IV clinical study analyzes what interactions people have when they take Zemuron and Etomidate. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,496 Etomidate users. Check the latest studies of Etomidate.

On Jul, 20, 2026

52 people who take Zemuron and Etomidate together, and have interactions are studied.

Zemuron and Etomidate drug interactions.

What are the common drug interactions of Zemuron and Etomidate, by gender? *:

female:

Aspartate aminotransferase increased
Blood glucose fluctuation
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Drug effect decreased
Electrocardiogram qt prolonged
Face oedema (swelling of face)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematochezia (passage of stools containing blood)

male:

Injury
Renal failure (kidney dysfunction)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Emotional distress
Infection
Renal failure acute (rapid kidney dysfunction)
Stress
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Cardiac arrest

What are the common drug interactions of Zemuron and Etomidate, by age (0-1 to 60+)? *:

0-1:

Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)

2-9:

n/a

10-19:

n/a

20-29:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Leukocytosis (increased white blood cells)
Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
Hyperglycaemia (high blood sugar)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory distress (difficulty in breathing)
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Drug hypersensitivity

30-39:

Anaemia (lack of blood)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Splenic infarction (tissue damage of spleen)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

40-49:

Alanine aminotransferase increased
Renal failure acute (rapid kidney dysfunction)
Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)
Tolerance increased

50-59:

Death
Injury
Pain
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)
Acute circulatory failure (shock)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Aspartate aminotransferase increased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Cardiac failure

60+:

Injury
Renal failure (kidney dysfunction)
Stress
Dyspnoea (difficult or laboured respiration)
Laryngeal oedema (swelling of larynx)
Asthenia (weakness)
Blood potassium increased
Blood pressure fluctuation
Blood sodium decreased
Cardiac arrest

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 9.62%
Pain: 4 people, 7.69%
Neuromuscular Blockade: 4 people, 7.69%
Urinary Tract Infection: 3 people, 5.77%
Pneumonia: 3 people, 5.77%
Migraine (headache): 3 people, 5.77%
Abdominal Infection: 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and Etomidate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously